Home > Boards > US Listed > Biotechs > INSMED (INSM)

I`m wondering how fast, with the new FDA

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
blueyedcatch Member Profile
 
Followed By 13
Posts 5,543
Boards Moderated 0
Alias Born 07/14/16
160x600 placeholder
Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020 PR Newswire (US) - 7/27/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 9:38:47 AM
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infect... PR Newswire (US) - 7/24/2020 7:39:00 AM
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infect... PR Newswire (US) - 7/24/2020 7:36:00 AM
New NTM Treatment Guidelines Recommend Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of Patient... PR Newswire (US) - 7/7/2020 8:00:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 7/6/2020 8:00:00 AM
Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis Presented at AT... PR Newswire (US) - 6/24/2020 4:01:00 PM
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCF... PR Newswire (US) - 6/8/2020 8:00:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 6/5/2020 8:00:00 AM
Insmed to Present at Two June Conferences PR Newswire (US) - 5/26/2020 8:00:00 AM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 5/21/2020 4:10:30 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/21/2020 4:08:11 PM
Insmed to Showcase New Brensocatib Data at American Thoracic Society Virtual Clinical Trials Session PR Newswire (US) - 5/20/2020 9:29:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 4:02:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2020 10:59:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2020 8:32:02 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 5/7/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/5/2020 5:30:59 PM
Insmed Announces Pricing of Public Offering of Common Stock PR Newswire (US) - 5/5/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/4/2020 4:13:29 PM
Insmed Announces Proposed Public Offering of Common Stock PR Newswire (US) - 5/4/2020 4:01:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/30/2020 7:31:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2020 7:31:37 AM
Insmed Reports First Quarter 2020 Financial Results and Provides Business Update PR Newswire (US) - 4/30/2020 7:30:00 AM
Brensocatib (Formerly INS1007) to be Studied in Patients with Severe COVID-19 in Investigator-Initiated Trial PR Newswire (US) - 4/23/2020 6:00:00 AM
blueyedcatch   Thursday, 09/07/17 08:53:39 PM
Re: Crazyjake27 post# 6446
Post # of 6484 
I`m wondering how fast, with the new FDA under Gottleib,we will see approval,especially when the CDC wants what we have, as well as the FDA practically holding Insmeds hand through this whole thing. Everyone wants it approved,so it`s just a question of how long. IMO,the EU will get us done for sure,and the FDA should be a gimme considering everything. So how long? Shorts aren`t gonna get anything because approval could happen anytime now,and the offering set the bottom while we wait for it.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist